𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells

✍ Scribed by Carl Y. Sasaki; Hsingchi Lin; Antonino Passaniti


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
539 KB
Volume
181
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis


Urokinase plasminogen activator (uPA) is involved in proteolysis of extracellular matrix during development and tumor cell invasion. In the present study, we examined the regulation of uPA in hormone-responsive, noninvasive mammary epithelial cells by using fibrinolytic and caseinolytic enzyme activity assays. Urokinase PA expression was activated after contact with fibrin and initiation of cell-cell interactions that were mediated by E-cadherin. Fibrinolysis occurred in zones surrounding cellular aggregates. Stromal matrix proteins that disrupted aggregation or anti-E-cadherin antibodies that inhibited cellular compaction inhibited fibrinolysis perhaps by increasing cell-matrix adhesion or preventing E-cadherin signaling, respectively. Aggregation required the presence of divalent cations and was inhibited by serum and ethylene diaminetetraacetic acid, whereas serine protease inhibitors reduced uPA activity without affecting aggregation. Inhibitors of PA (type 2; PAI-2) and a specific antisense uPA oligonucleotide also reduced enzymatic activity, suggesting that fibrinolysis depends on translational regulation of uPA. In addition, the activation of plasmin from plasminogen was inhibited by anti-E-cadherin antibodies and PAI-2, consistent with a role for uPA. The data also support a role for transcriptional regulation of uPA activity because treatment of cells with progesterone, hydrocortisone, or dexamethasone inhibited uPA activation on fibrin without affecting cellular aggregation. Estradiol and insulin did not alter, whereas human chorionic gonadotropin and prolactin increased uPA activity. The expression of the 55-kDa uPA activity was consistent with specific hormone action and correlated with protein expression by immunoblotting. Therefore, the alteration of downstream signaling events by hormones may affect uPA production. These results indicate that uPA is an enzyme that may be important in the degradation of extracellular matrix during development and that specific E-cadherin interactions and hormones can regulate its activity. Investigation of the regulation of uPA in these cells may be useful in understanding and manipulating mammary gland remodeling.


πŸ“œ SIMILAR VOLUMES


Heregulin inhibits proliferation via ERK
✍ Lydia Puricelli; Cecilia J. Proiettii; Leticia Labriola; Mariana Salatino; MarΓ­a πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 530 KB

Heregulin (HRG) and type I receptor tyrosine kinase (RTK) expression was investigated in the highly invasive and metastatic LM3 cell line, our previously described model of metastasis for mammary cancer (Bal de Kier Joffe et al. [1986] Invasion Metastasis 6:302-12; Urtreger et al. [1997] Int J Oncol

Regulation of cell morphology and adhesi
✍ Shaowei Li; Richard Braverman; Hongzhen Li; William C. Vass; Douglas R. Lowy; Je πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 542 KB

## Abstract We investigated the effects of overexpression of the tuberous sclerosis‐1 and ‐2 (__TSC1/2__) gene products (hamartin and tuberin, respectively) in the human kidney epithelial cell line 293 with an inducible expression system. As we had observed previously in fibroblasts, 293 cells over

Transforming growth factor Ξ²-1 and amphi
✍ Corinne Giusti; Sylvie Desruisseau; Lin Ma; Fabien Calvo; Pierre-Marie Martin; Y πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 276 KB πŸ‘ 1 views

## Abstract Amphireguline (AR) is an epidermal growth factor (EGF)‐related peptide that seems to play an important role in breast cancer progression. We have demonstrated recently that suppression of AR expression in transformed breast epithelial cells considerably reduced both size and neovascular